`571-272-7822
`
`
`
`
`
`
`
`
` Paper 56
`
`
`
` Entered: December 4, 2017
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`APOTEX INC. and APOTEX CORP.,
`Petitioners
`
`v.
`
`AMGEN INC. and AMGEN MANUFACTURING LIMITED,
`Patent Owner.
`____________
`
`Case IPR2016-01542
`Patent 8,952,138 B2
`____________
`
`
`
`Before JAMES T. MOORE, MICHAEL J. FITZPATRICK, and
`CHRISTOPHER G. PAULRAJ, Administrative Patent Judges.
`
`MOORE, Administrative Patent Judge.
`
`
`
`
`
` ORDER
`Oral Hearing
`37 C.F.R. § 42.70
`
`
`
`
`
`IPR2016-01542
`Patent 8,952,138 B2
`
`
`Apotex Inc. and Apotex Corp. (“Apotex” or “Petitioner”) and Amgen
`Inc. and Amgen Manufacturing Limited (“Amgen” or “Patent Owner”)
`requested a hearing in the above listed proceeding pursuant to 37 C.F.R.
`§ 42.70. Papers 38 and 39, filed October 12, 2017. The requests are granted.
`This proceeding will be heard on December 13, 2017, beginning at
`1:00 PM Eastern Time on the ninth floor of Madison Building East, 600
`Dulany Street, Alexandria, VA. Each party will have 60 minutes of
`argument time.
`In the hearing, Petitioner will argue first and may present arguments
`regarding the challenged claims on which we instituted trial and Petitioner’s
`Motion(s) to Exclude, as appropriate. Patent Owner then will have the
`opportunity to respond to Petitioner’s arguments, its Motion(s) to Exclude,
`and discuss its Motion to Submit Supplemental Information, as needed.
`Next, Petitioner may use any time it has reserved for rebuttal to respond to
`Patent Owner’s arguments, Patent Owner’s Motion(s) to Exclude, and
`Motion to Submit Supplemental Evidence. Finally, Patent Owner may use
`any time it has reserved for rebuttal to respond only to Petitioner’s
`arguments regarding Patent Owner’s Motion to Submit Supplemental
`Information and Motion(s) to Exclude. No other arguments will be heard.
`There is a strong public policy interest in making all information
`presented in these proceedings public, as the review determines the
`patentability of claims in an issued patent and thus affects the rights of the
`public. This policy is reflected in part, for example, in 35 U.S.C. § 316(a)(1)
`and 35 U.S.C. § 326(a)(1), which provide that the file of any inter partes
`review or post grant review be made available to the public, except that any
`2
`
`
`
`IPR2016-01542
`Patent 8,952,138 B2
`
`petition or document filed with the intent that it be sealed shall, if
`accompanied by a motion to seal, be treated as sealed pending the outcome
`of the ruling on the motion. Although there are motions to seal pending,
`neither party has requested that the oral hearing be closed to the public.
`Accordingly, the hearings will be open to the public for in-person
`attendance, which will be accommodated on a first-come, first-served basis.
`The Board will provide a court reporter. A transcript for the hearing
`will constitute the official record of the hearing. Any demonstrative exhibits
`must be served seven business days before the hearing. 37 C.F.R. § 42.70(b).
`Demonstrative exhibits are not evidence and may not introduce new
`evidence or arguments. Instead, demonstrative exhibits should cite to
`evidence in the record. The parties are directed to St. Jude Medical,
`Cardiology Division, Inc. v. The Board of Regents of the University of
`Michigan, Case No. IPR2013-00041 (PTAB Jan. 27, 2014) (Paper 65)
`regarding the appropriate content of demonstrative exhibits.
`Any issue regarding demonstrative exhibits should be resolved at least
`three days prior to the hearing by way of a joint telephone conference call to
`the Board. The parties are responsible for requesting such a conference
`sufficiently in advance of the hearing to accommodate this requirement. Any
`objection to demonstrative exhibits that is not timely presented will be
`considered waived. Demonstratives should be filed at the Board no later than
`two days before the hearing. A hard copy of the demonstratives should be
`provided to the court reporter at the hearing. Please note that, as some
`judges may attend remotely, failure to file the demonstratives might
`
`3
`
`
`
`IPR2016-01542
`Patent 8,952,138 B2
`
`mean the remotely attending judges may not be able to view the
`demonstratives.
`Questions regarding specific audio-visual equipment should be
`directed to the Board at (571) 272-9797. Requests for audio-visual
`equipment must be made 5 days in advance of the hearing date. The
`request is to be sent to Trials@uspto.gov. If the request is not timely
`received, the equipment may not be available on the day of the hearing.
`The Board expects lead counsel for each party to be present at the oral
`hearing, although any counsel of record may make the actual presentation. If
`either party anticipates that its lead counsel will not be attending the oral
`argument, the parties should initiate a joint telephone conference with the
`Board no later than two business days prior to the oral hearing to discuss the
`matter.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`IPR2016-01542
`Patent 8,952,138 B2
`
`PETITIONER:
`
`Teresa Rea
`trea@crowell.com
`
`Deborah Yellin
`dyellin@crowell.com
`
`Vincent Galluzzo
`vgalluzzo@crowell.com
`
`Michael Jacobs
`mjacobs@crowell.com
`
`Shannon Lentz
`slentz@crowell.com
`
`PATENT OWNER:
`
`Arlene Chow
`Arlene.chow@hoganlovells.com
`
`Catherine Nyarady
`cnyarady@paulweiss.com
`
`
`
`5
`
`